Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation
Introduction: Waldenström's macroglobulinemia (WM), an orphan disease, is a rare low-
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation.
M Migkou, D Fotiou, M Gavriatopoulou… - Expert Opinion on …, 2021 - europepmc.org
Introduction: Waldenström's macroglobulinemia (WM), an orphan disease, is a rare low-
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation
M Migkou, D Fotiou… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: Waldenström's macroglobulinemia (WM), an orphan disease, is a rare low-
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …
grade B-cell lymphoplasmacytic lymphoma with unique clinical features and monoclonal …